JP2024537910A5 - - Google Patents
Info
- Publication number
- JP2024537910A5 JP2024537910A5 JP2024523598A JP2024523598A JP2024537910A5 JP 2024537910 A5 JP2024537910 A5 JP 2024537910A5 JP 2024523598 A JP2024523598 A JP 2024523598A JP 2024523598 A JP2024523598 A JP 2024523598A JP 2024537910 A5 JP2024537910 A5 JP 2024537910A5
- Authority
- JP
- Japan
- Prior art keywords
- component
- less
- approximately
- pharmaceutically acceptable
- injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202121047991 | 2021-10-21 | ||
| IN202121047991 | 2021-10-21 | ||
| PCT/IB2022/060145 WO2023067569A1 (en) | 2021-10-21 | 2022-10-21 | Stable ready to dilute composition of carfilzomib |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024537910A JP2024537910A (ja) | 2024-10-16 |
| JP2024537910A5 true JP2024537910A5 (https=) | 2025-11-20 |
Family
ID=86058874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523598A Pending JP2024537910A (ja) | 2021-10-21 | 2022-10-21 | 安定した希釈準備済みカルフィルゾミブ組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12440534B2 (https=) |
| EP (1) | EP4419080A4 (https=) |
| JP (1) | JP2024537910A (https=) |
| CN (1) | CN118434408A (https=) |
| AU (1) | AU2022369145A1 (https=) |
| CA (1) | CA3235911A1 (https=) |
| WO (1) | WO2023067569A1 (https=) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5877205A (en) * | 1996-06-28 | 1999-03-02 | Board Of Regents, The University Of Texas System | Parenteral paclitaxel in a stable non-toxic formulation |
| WO2015198257A1 (en) * | 2014-06-26 | 2015-12-30 | Intas Pharmaceuticals Ltd. | Stable carfilzomib injection |
| WO2016116882A2 (en) * | 2015-01-23 | 2016-07-28 | Leiutis Pharmaceuticals Pvt Ltd | Novel compositions of carfilzomib |
| WO2016185450A1 (en) * | 2015-05-21 | 2016-11-24 | Laurus Labs Private Limited | An improved processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof |
| WO2018047074A1 (en) * | 2016-09-07 | 2018-03-15 | Cadila Healthcare Limited | Sterile injectable compositions comprising drug micelles |
| US10098890B2 (en) * | 2016-10-29 | 2018-10-16 | Cipla Limited | Stable carfilzomib formulations |
| WO2018138557A1 (en) * | 2017-01-24 | 2018-08-02 | Orbicular Pharmaceutical Technologies Pvt. Ltd. | Ready-to-use carfilzomib compositions |
| US20260048003A1 (en) * | 2020-01-10 | 2026-02-19 | Amgen Inc. | Stable cyclodextrin free carfilzomib formulation |
| CA3180338A1 (en) * | 2020-04-15 | 2021-10-21 | Kashiv Biosciences, Llc | Stable ready to dilute formulations of carfilzomib |
-
2022
- 2022-10-21 EP EP22883094.9A patent/EP4419080A4/en active Pending
- 2022-10-21 WO PCT/IB2022/060145 patent/WO2023067569A1/en not_active Ceased
- 2022-10-21 JP JP2024523598A patent/JP2024537910A/ja active Pending
- 2022-10-21 CA CA3235911A patent/CA3235911A1/en active Pending
- 2022-10-21 AU AU2022369145A patent/AU2022369145A1/en active Pending
- 2022-10-21 CN CN202280084662.4A patent/CN118434408A/zh active Pending
-
2024
- 2024-04-19 US US18/640,730 patent/US12440534B2/en active Active
-
2025
- 2025-09-16 US US19/330,434 patent/US20260014226A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7160433B2 (ja) | ロキソプロフェン配合皮膚用外用剤 | |
| US20200282057A1 (en) | Formulations of bendamustine | |
| JP7091477B2 (ja) | エダラボン医薬組成物 | |
| CN1893938A (zh) | 普瑞巴林组合物 | |
| CN102573852A (zh) | 用于治疗ibd的药物组合物 | |
| CN102516298A (zh) | 左旋奥硝唑磷酸酯稳定的药用盐及其制备方法和用途 | |
| CN105078909B (zh) | 一种注射用苯磺顺阿曲库铵冷冻干燥组合物及其制备方法 | |
| PT90356B (pt) | Processo para a preparacao de composicoes farmaceuticas contendo solucoes aquosas de pentamidina | |
| TW200526268A (en) | Injectable composition | |
| CN115813920A (zh) | 1,2,4三唑并4,3-b哒嗪衍生物在制备治疗慢性肾病的药物中的应用 | |
| JP6498610B2 (ja) | カバジタキセル組成物 | |
| JP2024537910A5 (https=) | ||
| CN101288650B (zh) | 一种依达拉奉的冻干制剂及其制备工艺 | |
| JP2021514393A (ja) | 複数回使用のトラセミド組成物 | |
| JP5128003B2 (ja) | 腹膜透析患者用の経口医薬組成物及びその用法 | |
| JP2020059747A (ja) | エピナスチン含有点眼液 | |
| TWI649097B (zh) | 乙醯胺酚之可注射製劑 | |
| JPWO2016121147A1 (ja) | 注腸剤 | |
| JP2018108993A (ja) | 注腸剤 | |
| CN101155584A (zh) | 给药伊沙匹隆的方法 | |
| CN111511222B (zh) | 用于钙补充的组合物 | |
| CN105769849B (zh) | 一种治疗卵巢癌的药物组合物 | |
| JP7534129B2 (ja) | 多成分配合点眼剤 | |
| US20170000727A1 (en) | Dry enema product | |
| JP7267640B2 (ja) | 希釈安定性に優れたテニポシド注射用溶液及びその調製方法 |